1. From the Institute of Molecular Oncology (IFOM) of the Italian Foundation for Cancer Research, Milan, Italy; the European Institute of Oncology, Milan, Italy; the Institute of Hematology, University of Perugia, Perugia, Italy; the Institute of Hematology, University La Sapienza, Rome, Italy; and the Department of Biopathology, University of Tor Vergata, Rome, Italy.